Life sciences news
-
Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels
Tuesday June 15th 2021
Read more
-
Vacature: Manager Studiedienst (m/v/x) bij flanders.bio
Monday June 14th 2021
Read more
-
Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics
Monday June 14th 2021
Read more
-
Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™
Monday June 14th 2021
Read more
-
OXURION confirms Institutional Review Board approval and submission of the Investigational New Drug Application to the FDA to start Phase 2 Study evaluating THR-687 for Diabetic Macular Edema (DME)
Thursday June 10th 2021
Read more
-
Biotalys nominates Catherine Moukheibir to its Board of Directors
Thursday June 10th 2021
Read more
-
argenx to regain global rights to cusatuzumab
Tuesday June 8th 2021
Read more
-
OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
Tuesday June 8th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Friday June 4th 2021
Read more
-
RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV
Wednesday June 2nd 2021
Read more
-
argenx appoints Karl Gubitz as Chief Financial Officer
Wednesday June 2nd 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
